The effect of ranibizumab and aflibercept treatment on the prevalence of outer retinal tubulation and its influence on retreatment in neovascular age-related macular degeneration.
Kovacs, Attila
The effect of ranibizumab and aflibercept treatment on the prevalence of outer retinal tubulation and its influence on retreatment in neovascular age-related macular degeneration. [electronic resource] - BMC ophthalmology Nov 2018 - 298 p. digital
Publication Type: Journal Article
1471-2415
10.1186/s12886-018-0960-6 doi
Aged
Aged, 80 and over
Angiogenesis Inhibitors--therapeutic use
Biomarkers
Female
Humans
Macular Degeneration--drug therapy
Male
Middle Aged
Prevalence
Ranibizumab--therapeutic use
Receptors, Vascular Endothelial Growth Factor--therapeutic use
Recombinant Fusion Proteins--therapeutic use
Retina--pathology
Retreatment
Retrospective Studies
Visual Acuity
The effect of ranibizumab and aflibercept treatment on the prevalence of outer retinal tubulation and its influence on retreatment in neovascular age-related macular degeneration. [electronic resource] - BMC ophthalmology Nov 2018 - 298 p. digital
Publication Type: Journal Article
1471-2415
10.1186/s12886-018-0960-6 doi
Aged
Aged, 80 and over
Angiogenesis Inhibitors--therapeutic use
Biomarkers
Female
Humans
Macular Degeneration--drug therapy
Male
Middle Aged
Prevalence
Ranibizumab--therapeutic use
Receptors, Vascular Endothelial Growth Factor--therapeutic use
Recombinant Fusion Proteins--therapeutic use
Retina--pathology
Retreatment
Retrospective Studies
Visual Acuity